Literature DB >> 15949648

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

Jose de Leon1, Francisco J Diaz.   

Abstract

A meta-analysis of worldwide studies, found by a 10-year literature follow-up and/or by searching PubMed, was performed. Forty-two studies across 20 nations consistently demonstrated an association between schizophrenia and current smoking (weighted average odds ratio, OR=5.9; 95% confidence interval, CI 4.9--5.7). In 32 male studies across 18 nations, the weighted average OR was 7.2 (CI, 6.1--8.3). In 25 female studies across 15 nations, the weighted average OR was 3.3 (CI, 3.0--3.6). The association between schizophrenia and current smoking remained after using severe mentally ill controls (18 studies across 9 countries, weighted average OR was 1.9, CI 1.7--2.1) and controlling for other variables (3 studies, adjusted ORs ranged 2-3). Heavy smoking (6 studies across 4 countries, ORs ranged 1.9--6.4) and high nicotine dependence were more frequent in smokers with schizophrenia versus the general population. There was no consistent evidence that heavy smoking or high nicotine dependence was more frequent in smokers with schizophrenia versus severe mentally ill controls. Cessation rates were lower in schizophrenia smokers versus the general population. Schizophrenia patients had a higher prevalence of ever smoking than the general population (9 studies across 6 countries, weighted average OR=3.1, CI 2.4--3.8) and than severe mentally ill patients (5 studies across 5 countries, OR=2.0, CI 1.6--2.4). Moreover, in two studies adjusting for confounders schizophrenia patients had an increased risk of starting daily smoking than controls. Thus, people who are going to develop schizophrenia have risk factors that make them more vulnerable to start smoking.

Entities:  

Mesh:

Year:  2005        PMID: 15949648     DOI: 10.1016/j.schres.2005.02.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  402 in total

1.  Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Authors:  Clare Meernik; Anna McCullough; Leah Ranney; Barbara Walsh; Adam O Goldstein
Journal:  Community Ment Health J       Date:  2017-08-02

2.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

3.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

4.  Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.

Authors:  Christian Luckhaus; Uwe Henning; Stefano Ferrea; Francesco Musso; Arian Mobascher; Georg Winterer
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

5.  Premature to conclude no genetic basis to the association between smoking and major depressive disorder.

Authors:  David Lawrence; Francis Mitrou; Stephen R Zubrick
Journal:  Hum Genet       Date:  2012-04-13       Impact factor: 4.132

6.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

7.  Tobacco craving in smokers with and without schizophrenia.

Authors:  Suzanne Lo; Stephen J Heishman; Heather Raley; Katherine Wright; Heidi J Wehring; Eric T Moolchan; Stephanie Feldman; Fang Liu; Robert P McMahon; Charles M Richardson; Deanna L Kelly
Journal:  Schizophr Res       Date:  2010-07-15       Impact factor: 4.939

8.  Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.

Authors:  Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton
Journal:  Schizophr Res       Date:  2018-02-04       Impact factor: 4.939

Review 9.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

10.  Is smoking tobacco associated with psychotic experiences across racial categories in the United States? Findings from the Collaborative Psychiatric Epidemiological Surveys.

Authors:  Hans Y Oh; Ai Koyanagi; Fiza Singh; Jordan DeVylder
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.